| Literature DB >> 25358321 |
G P Mandal, T K Ghosh, A K Patra.
Abstract
The objective of this study was to investigate the different dietary ratios of n-6 to n-3 (n-6/n-3) fatty acid (FA) on performance and n-6/n-3 FA in muscles of broiler chickens. A total of 300 one-day-old Cobb chicks were randomly assigned to 3 treatments of 10 replicates in each (10 birds/replicate). Birds were fed on a corn-soybean meal-based diet containing 1% oil during starter (day 1 to 21) and 2% oil during finisher (day 22 to 39) phases, respectively. Treatments of high, medium and low dietary n-6/n-3 FA were formulated by replacing rice bran oil with linseed oil to achieve n-6/n-3 FA close to >20:1, 10:1 and 5:1, respectively. Average daily gain, average daily feed intake, and feed conversion ratio were similar (p>0.05) among the treatments. Serum glucose, cholesterol and triglycerides concentrations were not affected (p>0.05) by dietary treatments. In breast, concentration of C18:3n-3 was significantly greater (p = 0.001) for medium and low vs high n-6/n-3 FA, while concentrations of C20:5n-3, C22:6n-3, total n-3 FA, and n-6/n-3 FA were significantly higher for low vs medium, and medium vs high dietary n-6/n-3 FA. In contrast, concentrations of C18:2 and mono-unsaturated FA (MUFA) were lower for low vs high dietary n-6/n-3 FA. In thigh muscles, concentrations of C20:5n-3 were higher (p<0.05) for medium and low vs high dietary n-6/n-3 FA, and concentrations of C18:3n-3, C22:6, and n-3 FA were greater (p<0.05) for medium vs high, low vs medium dietary n-6/n-3 FA. However, concentrations of C18:1, MUFA, n-6/n-3 were lower (p<0.05) for low and medium vs high dietary n-6/n-3 FA. In conclusion, lowering the dietary n-6/n-3 FA did not affect the performance of chickens, but enhanced beneficial long-chain n-3 FA and decreased n-6/n-3 FA in chicken breast and thigh, which could be advantageous for obtaining healthy chicken products.Entities:
Keywords: Chicken; Meat; Performance; n-6 to n-3 Fatty Acid Ratio
Year: 2014 PMID: 25358321 PMCID: PMC4213706 DOI: 10.5713/ajas.2014.14013
Source DB: PubMed Journal: Asian-Australas J Anim Sci ISSN: 1011-2367 Impact factor: 2.509
Ingredient composition and nutrient content of experimental diet
| Item | n-6 to n-3 FA ratio | |||||
|---|---|---|---|---|---|---|
|
| ||||||
| Starter (day 1–21) | Grower (day 22–39) | |||||
|
|
| |||||
| High | Medium | Low | High | Medium | Low | |
| Ingredients (%) | ||||||
| Maize | 64 | 64 | 64 | 67.09 | 67.09 | 67.09 |
| Soybean meal (CP-44%) | 31.04 | 31.04 | 31.04 | 27.51 | 27.51 | 27.51 |
| Rice bran oil | 1 | 0.7 | 0.3 | 2 | 1.6 | 1.0 |
| Linseed oil | 0 | 0.3 | 0.7 | 0 | 0.4 | 1.0 |
| Limestone powder | 1.76 | 1.76 | 1.76 | 1.47 | 1.47 | 1.47 |
| Dicalcium phosphate | 0.77 | 0.77 | 0.77 | 0.71 | 0.71 | 0.71 |
| Sodium chloride | 0.38 | 0.38 | 0.38 | 0.25 | 0.25 | 0.25 |
| DL-methionine | 0.33 | 0.33 | 0.33 | 0.37 | 0.37 | 0.37 |
| L-lysine HCl | 0.37 | 0.37 | 0.37 | 0.22 | 0.22 | 0.22 |
| L-threonine | 0.12 | 0.12 | 0.12 | 0.1 | 0.1 | 0.1 |
| Vitamin premix | 0.0125 | 0.0125 | 0.0125 | 0.0125 | 0.0125 | 0.0125 |
| Madhuramicine | 0.05 | 0.05 | 0.05 | 0.05 | 0.05 | 0.05 |
| Betaine HCl | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 |
| Organic trace minerals | 0.05 | 0.05 | 0.05 | 0.05 | 0.05 | 0.05 |
| Antioxidant | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 |
| Phytase | 0.01 | 0.01 | 0.01 | 0.05 | 0.05 | 0.05 |
| Nutrient content (% DM basis) | 0.01 | 0.01 | 0.01 | |||
| DM | 92.15 | 92.32 | 91.82 | 92.42 | 92.04 | 92.27 |
| CP | 19.52 | 19.46 | 19.55 | 17.97 | 18.03 | 18.05 |
| ME (kcal/kg) | 2,945 | 2,945 | 2,945 | 3,050 | 3,050 | 3,050 |
| EE | 3.92 | 3.96 | 3.87 | 4.72 | 4.67 | 4.68 |
| Methionine | 0.61 | 0.61 | 0.61 | 0.63 | 0.63 | 0.63 |
| Lysine | 1.25 | 1.25 | 1.25 | 1.05 | 1.05 | 1.05 |
| Methionine+cysteine | 0.91 | 0.91 | 0.91 | 0.88 | 0.88 | 0.88 |
| Threonine | 0.82 | 0.82 | 0.82 | 0.75 | 0.75 | 0.75 |
| Ca | 0.92 | 0.89 | 0.90 | 0.79 | 0.81 | 0.77 |
| Available P | 0.45 | 0.45 | 0.45 | 0.40 | 0.40 | 0.40 |
FA, fatty acid; CP, crude protein; DM, dry matter; ME, metabolizable energy; EE, ether extract.
Contains (per kg): vitamin A, 80,000,000 IU; vitamin D3, 16,000,000 I.U; vitamin E, 64 g; vitamin K, 8 g; vitamin B1, 6.4 g; vitamin B2, 40 g, niacin, 96 g, pantothenic acid, 64 g; vitamin B6, 12.8 g; folic acid 6.4 g; vitamin B12, 0.164 g; biotin, 0.24 g.
Contains (per kg): Zn proteinate, 50 g; Fe proteinate, 30 g; Cu proteinate, 10 g; Se proteinate, 0.5 g; Mn proteinate, 50 g; I, 4 g; Cu proteinate, 0.4 g (Organomin, Zeus Biotech Lmited, Mysore, India).
Endox (Kemin Industries, Inc., USA).
Quantam Blue (A.B. Vista, Marlborough, Wiltshire, UK).
Calculated value.
Fatty acid (FA) concentrations of starter diet and finisher diet (g/100 g of total FA)
| Item | n-6 to n-3 FA ratio | |||||
|---|---|---|---|---|---|---|
|
| ||||||
| Starter | Finisher | |||||
|
|
| |||||
| High | Medium | Low | High | Medium | Low | |
| Total FA (%) | 2.06 | 1.97 | 1.98 | 2.97 | 2.92 | 2.85 |
| C14:0 | 0.17 | 0.20 | 0.18 | 0.21 | 0.18 | 0.16 |
| C16:0 | 17.73 | 18.63 | 16.95 | 17.98 | 17.52 | 16.09 |
| C16:1 | 0.20 | 0.18 | 0.23 | 0.16 | 0.16 | 0.16 |
| C18:0 | 2.17 | 2.16 | 2.45 | 2.24 | 2.25 | 2.28 |
| C18:1 | 30.71 | 30.88 | 31.99 | 33.96 | 33.64 | 30.27 |
| C18:2n-6 | 44.85 | 42.50 | 39.67 | 41.67 | 40.01 | 39.90 |
| C18:3n-6 | 0.16 | 0.18 | 0.19 | 0.18 | 0.20 | 0.18 |
| C18:3n-3 | 2.09 | 4.05 | 6.70 | 1.65 | 3.91 | 7.38 |
| C20:1 | 0.22 | 0.23 | 0.34 | 0.26 | 0.27 | 0.28 |
| SFA | 20.07 | 20.99 | 19.57 | 20.42 | 19.95 | 18.98 |
| MUFA | 31.13 | 31.29 | 32.56 | 34.38 | 34.06 | 30.70 |
| PUFA | 47.10 | 46.72 | 46.57 | 43.50 | 44.12 | 47.46 |
| n-6 to n-3 ratio | 21.55 | 10.54 | 5.95 | 25.33 | 10.27 | 5.43 |
SFA, saturated fatty acid; MUFA, mono-unsaturated fatty acid; PUFA, poly-unsaturated fatty acid.
ADG (g), ADFI (g), FCR, and blood glucose, cholesterol and triglyceride concentration (mg/dL) of broiler chicken fed diets with different ratios of n-6 to n-3 fatty acids (FA)
| Item | FA n-6 to n-3 ratio | SEM | p-value | ||
|---|---|---|---|---|---|
|
| |||||
| High | Medium | Low | |||
| ADG | |||||
| 1–21 d | 31.03 | 32.15 | 31.41 | 0.272 | 0.239 |
| 22–39 d | 61.46 | 59.16 | 62.73 | 0.765 | 0.155 |
| 1–39 d | 45.08 | 44.61 | 45.87 | 0.369 | 0.389 |
| ADFI | |||||
| 1–21 d | 42.70 | 43.06 | 42.73 | 0.245 | 0.814 |
| 22–39 d | 104.1b | 104.2b | 108.8a | 0.854 | 0.032 |
| 1–39 d | 71.02 | 71.28 | 73.21 | 0.457 | 0.100 |
| FCR | |||||
| 1–21 d | 1.37 | 1.34 | 1.36 | 0.012 | 0.456 |
| 22–39 | 1.70 | 1.77 | 1.74 | 0.023 | 0.527 |
| 1–39 d | 1.58 | 1.60 | 1.60 | 0.015 | 0.800 |
| Blood parameters | |||||
| Glucose | 289.9 | 265.4 | 297.4 | 8.85 | 0.321 |
| Cholesterol | 129.9 | 121.6 | 152.2 | 7.06 | 0.188 |
| Triglycerides | 153.4 | 108.3 | 115.8 | 10.92 | 0.203 |
ADG, average daily gain; ADFI, average daily feed intake; SEM, standard error of the mean; FCR, feed conversion ratio.
Means with different superscript letter differ significantly (p<0.05) among the treatments.
Fatty acid (FA) concentrations (g/100 g of total FA) in breast muscles of broiler chicken fed diets with different n-6 to n-3 FA ratios
| Item | FA n-6 to n-3 ratio | SEM | p-value | ||
|---|---|---|---|---|---|
|
| |||||
| High | Medium | Low | |||
| FA (g/100 g offresh tissue) | 0.82 | 0.72 | 0.73 | 0.044 | 0.603 |
| C14:0 | 0.58 | 0.51 | 0.44 | 0.029 | 0.156 |
| C16:0 | 23.50 | 23.11 | 22.27 | 0.223 | 0.065 |
| C16:1 | 3.16 | 2.80 | 2.35 | 0.212 | 0.304 |
| C17:1 | 0.41 | 0.53 | 0.60 | 0.034 | 0.074 |
| C18:0 | 9.17 | 9.92 | 10.40 | 0.249 | 0.127 |
| C18:1 | 25.85 | 24.22 | 22.58 | 0.649 | 0.118 |
| C18:2 n-6 | 17.79a | 17.08ab | 16.41b | 0.216 | 0.026 |
| C18:3 n-3 | 0.33b | 0.86a | 0.98a | 0.083 | 0.001 |
| C20:1 | 0.32 | 0.30 | 0.34 | 0.025 | 0.828 |
| C20:2 | 0.55 | 0.56 | 0.61 | 0.051 | 0.881 |
| C20:3 | 1.37 | 3.55 | 1.65 | 0.606 | 0.290 |
| C20:4n-6 | 6.59 | 6.25 | 6.91 | 0.327 | 0.729 |
| C20:5 n-3 | 0.15c | 0.50b | 0.98a | 0.079 | <0.001 |
| C22:6 n-3 | 0.43c | 0.88b | 1.77a | 0.137 | <0.001 |
| C24:1 | 0.85a | 0.88a | 0b | 0.118 | <0.001 |
| SFA | 33.66 | 34.06 | 33.71 | 0.207 | 0.713 |
| MUFA | 30.20a | 28.20ab | 25.26b | 0.832 | 0.044 |
| PUFA | 27.20 | 27.88 | 29.33 | 0.451 | 0.147 |
| Total n-6 | 26.30 | 25.63 | 25.59 | 0.389 | 0.724 |
| Total n-3 | 0.90c | 2.25b | 3.74a | 0.253 | <0.001 |
| n-6 to n-3 ratio | 28.92a | 11.80b | 6.92c | 2.098 | <0.001 |
SEM, standard error of mean; SFA, saturated fatty acid; MUFA, mono-unsaturated fatty acid; PUFA, poly-unsaturated fatty acid.
Means with different superscript letter differ significantly (p<0.05) among the treatments.
Fatty acid (FA) concentrations (g/100 g of total FA) in thigh muscles of broiler chicken fed diets with different n-6 to n-3 FA ratios
| Item | FA n-6 to n-3 ratio | SEM | p-value | ||
|---|---|---|---|---|---|
|
| |||||
| High | Medium | Low | |||
| FA (g/100 g offresh tissue) | 1.47 | 1.37 | 1.30 | 0.043 | 0.265 |
| C14:0 | 0.47 | 0.41 | 0.54 | 0.066 | 0.717 |
| C16:0 | 24.37a | 22.77b | 23.37ab | 0.252 | 0.024 |
| C16:1 | 3.84 | 2.56 | 2.61 | 0.288 | 0.118 |
| C17:1 | 0.08 b | 0.09b | 0.31a | 0.042 | 0.036 |
| C18:0 | 8.20 b | 10.67a | 10.61a | 0.435 | 0.022 |
| C18:1 | 29.23a | 23.05b | 22.63b | 1.096 | 0.015 |
| C18:2n-6 | 20.18 | 19.64 | 19.76 | 0.222 | 0.602 |
| C18:3n-3 | 0.41c | 0.82b | 1.20a | 0.086 | <0.001 |
| C20:1 | 0.16 | 0.30 | 0.26 | 0.027 | 0.084 |
| C20:2 | 0.29 | 0.34 | 0.22 | 0.032 | 0.281 |
| C20:3 | 0.81 | 1.13 | 1.09 | 0.083 | 0.237 |
| C20:4n-6 | 4.66 | 6.50 | 6.27 | 0.436 | 0.175 |
| C20:5n-3 | 0.07b | 0.35a | 0.48a | 0.044 | <0.001 |
| C22:6n-3 | 0.20c | 0.71b | 1.23a | 0.113 | <0.001 |
| C24:1 | 0.75a | 0.86a | 0.25b | 0.092 | 0.008 |
| SFA | 33.04 | 33.85 | 34.52 | 0.315 | 0.158 |
| MUFA | 34.06a | 26.86b | 26.06b | 1.337 | 0.019 |
| PUFA | 26.63 | 29.49 | 30.24 | 0.736 | 0.103 |
| Total n-6 | 25.95 | 27.62 | 27.33 | 0.668 | 0.571 |
| Total n-3 | 0.68c | 1.88b | 2.91a | 0.201 | <0.001 |
| n-6 to n-3 ratio | 40.06a | 15.27b | 9.51b | 3.122 | <0.001 |
SEM, standard error of mean; SFA, saturated fatty acid; MUFA, mono-unsaturated fatty acid; PUFA, poly-unsaturated fatty acid.
Means with different superscript letter differ significantly (p<0.05) among the treatments.